{
  "thread": {
    "uuid": "6441469accda5f81a9ab8f54900a9813dce090a3",
    "url": "https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/aiassist/pzzd/2026-01-15/doc-inhhkmpv3311568.shtml&from=redirect",
    "site_full": "cj.sina.cn",
    "site": "sina.cn",
    "site_section": "https://finance.sina.cn/",
    "site_categories": [
      "top_news_hk",
      "top_news_my",
      "top_news_sg",
      "top_news_tw",
      "top_news",
      "politics",
      "science and technology",
      "economy, business and finance"
    ],
    "section_title": "新浪财经_金融信息服务商",
    "site_title": "财经头条_新浪财经_金融信息服务商",
    "title": "艾力斯跌2.01%，成交额3.57亿元，主力资金净流出1483.23万元",
    "title_full": "艾力斯跌2.01%，成交额3.57亿元，主力资金净流出1483.23万元",
    "published": "2026-01-15T07:55:00.000+02:00",
    "replies_count": 0,
    "participants_count": 0,
    "site_type": "news",
    "country": "CN",
    "main_image": "https://n.sinaimg.cn/finance/c30320b4/20210712/wx_poster_finance1.png",
    "performance_score": 0,
    "domain_rank": 4801,
    "domain_rank_updated": "2026-01-11T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "6441469accda5f81a9ab8f54900a9813dce090a3",
  "url": "https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/aiassist/pzzd/2026-01-15/doc-inhhkmpv3311568.shtml&from=redirect",
  "ord_in_thread": 0,
  "author": null,
  "published": "2026-01-15T07:55:00.000+02:00",
  "title": "艾力斯跌2.01%，成交额3.57亿元，主力资金净流出1483.23万元",
  "text": "1月15日， 艾力斯 盘中下跌2.01%，截至13:55，报100.15元/股，成交3.57亿元，换手率0.78%，总市值450.68亿元。\n资金流向方面，主力资金净流出1483.23万元，特大单买入1006.09万元，占比2.82%，卖出1029.79万元，占比2.89%；大单买入5937.22万元，占比16.65%，卖出7396.75万元，占比20.75%。\n艾力斯今年以来股价跌3.84%，近5个交易日跌3.89%，近20日跌0.44%，近60日跌3.63%。\n资料显示， 上海艾力斯医药科技股份有限公司 位于上海市浦东新区周浦镇凌霄花路268号，成立日期2004年3月22日，上市日期2020年12月2日，公司主营业务涉及创新药物的研发、生产和销售。主营业务收入构成为：药品销售收入99.93%，推广服务收入0.06%，其他0.00%。\n艾力斯所属申万行业为： 医药生物 -化学 制药 -化学制剂。所属概念板块包括：MSCI中国、百元股、 基金重仓 、 融资融券 、中盘等。\n截至9月30日，艾力斯股东户数1.91万，较上期增加46.82%；人均流通股23551股，较上期减少31.89%。2025年1月-9月，艾力斯实现营业收入37.33亿元，同比增长47.35%；归母净利润16.16亿元，同比增长52.01%。\n分红 方面，艾力斯A股上市后累计派现6.53亿元。\n机构持仓方面，截止2025年9月30日，艾力斯十大流通股东中，香港中央结算有限公司位居第四大流通股东，持股2094.71万股，相比上期增加1056.93万股。 中欧医疗健康混合A （003095）位居第八大流通股东，持股859.51万股，相比上期减少55.75万股。易方达上证科创板50ETF（588080）位居第九大流通股东，持股828.14万股，相比上期减少103.11万股。华夏上证科创板50成份ETF（588000）位居第十大流通股东，持股796.44万股，相比上期减少445.65万股。\n打开App看更多精彩内容",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance"
  ],
  "topics": [
    "Economy, Business and Finance->market and exchange",
    "Economy, Business and Finance->investment and opinion pieces"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": true,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_my",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2026-01-15T08:02:29.566+02:00",
  "updated": "2026-01-16T08:08:08.000+02:00"
}